Close Menu

NEW YORK (GenomeWeb) – Natera reported after the close of the market on Tuesday that its second quarter 2017 revenues were up 3 percent.

The San Carlos, California-based molecular diagnostics company reported total Q2 2017 revenues of $53.6 million compared to $52.0 million in Q2 2016, beating analysts' average estimate of $50.6 million. Total revenues included $52.3 million in product revenue and $1.3 million in licensing and other revenue.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.